巨噬细胞调控多房棘球蚴病所致肝纤维化研究进展

doi:10.12140/j.issn.1000-7423.2024.06.015

中国寄生虫学与寄生虫病杂志 ›› 2024, Vol. 42 ›› Issue (6): 790-795.doi: 10.12140/j.issn.1000-7423.2024.06.015

巨噬细胞调控多房棘球蚴病所致肝纤维化研究进展

尹先敏¹(), 种世桂¹^,², 陈根¹, 秦俊梅¹, 赵玉敏¹^,²^,^*()

1 桂林医学院基础医学院人体寄生虫学教研室，广西桂林 541199
2 甘肃医学院，甘肃平凉 744099

收稿日期:2024-05-28 修回日期:2024-09-26 出版日期:2024-12-30 发布日期:2025-01-14
通讯作者: *赵玉敏（1971—），男，博士，教授，主要从事寄生虫病防治研究。E-mail：zymcsg@sina.com
作者简介:尹先敏（1998—），女，硕士研究生，主要从事寄生虫病防治研究。E-mail：yinxianmin2022@163.com
基金资助:
国家自然基金地区项目(82460403);甘肃省高等学校产业支撑计划项目(2022CYZC-72)

Research progress of macrophage regulation of liver fibrosis induced by alveolar echinococcosis

YIN Xianmin¹(), CHONG Shigui¹^,², CHEN Gen¹, QIN Junmei¹, ZHAO Yumin¹^,²^,^*()

1 Department of Parasitology, School of Basic Medical Sciences, Guilin Medical University, Guilin 541199, Guangxi, China
2 Gansu Medical Colledge, Pingliang 744099, Gansu, China

Received:2024-05-28 Revised:2024-09-26 Online:2024-12-30 Published:2025-01-14
Contact: *E-mail: zymcsg@sina.com
Supported by:
National Natural Science Foundation of China(82460403);Industrial Support Program Project for Colleges and Universities in Gansu Province(2022CYZC-72)

摘要/Abstract

摘要：

多房棘球蚴病（AE）是一种严重危害人类健康和畜牧业发展的人兽共患寄生虫病。AE病变周围各种免疫细胞（包括巨噬细胞）浸润增加，可造成以肝脏为主的多种重要器官纤维化，并可能发展成肝硬化和肝癌等严重疾病。几种巨噬细胞在AE肝脏炎症的进程以及纤维化形成的不同时期分别表现为M1型巨噬细胞或M2型巨噬细胞,并分泌促炎细胞因子和抗炎细胞因子,以此来促进早期棘球蚴的清除作用和中晚期的抗炎作用从而在AE肝脏纤维化的形成过程中发挥调控作用。本文从AE所致肝脏纤维化中几种巨噬细胞的调控机制作一论述。

关键词: 多房棘球蚴病, 巨噬细胞, 肝脏纤维化

Abstract:

Alveolar echinococcosis (AE) is a zoonotic parasitic disease that poses a serious threat to human health and the development of animal husbandry. The augmented infiltration of various immune cells (including macrophages) around AE lesions can lead to fibrosis in various important organs, primarily the liver, and might progress into cirrhosis, liver cancer, and other serious disorders. Several types of macrophages manifest as M1 or M2 macrophages at different stages of AE liver inflammation and fibrosis formation, secreting pro-inflammatory and anti-inflammatory cytokines to promote the clearance of echinococcus in the early stage and exerting an anti-inflammatory effect in the middle and late stages, thereby playing a regulatory role in AE liver fibrosis formation. In this article, the regulatory mechanisms of several types of macrophages in AE-induced liver fibrosis are discussed.

Key words: Alveolar Echinococcosis, Macrophage, Liver Fibrosis

中图分类号:

R532.32

尹先敏, 种世桂, 陈根, 秦俊梅, 赵玉敏. 巨噬细胞调控多房棘球蚴病所致肝纤维化研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(6): 790-795.

YIN Xianmin, CHONG Shigui, CHEN Gen, QIN Junmei, ZHAO Yumin. Research progress of macrophage regulation of liver fibrosis induced by alveolar echinococcosis[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2024, 42(6): 790-795.

图/表 1

参考文献 52

[1]	Liu HD, Wang HB, Fan HN, et al. Alveolar echinococcosis and immune evasion[J]. Chin J Parasitol Parasit Dis, 2018, 36(6): 655-660. (in Chinese)
	(刘寒冬, 王宏宾, 樊海宁, 等. 多房棘球蚴病的免疫逃避机制[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(6): 655-660.)
[2]	Beschin A, De Baetselier P, van Ginderachter JA. Contribution of myeloid cell subsets to liver fibrosis in parasite infection[J]. J Pathol, 2013, 229(2): 186-197.
[3]	Joliat GR, Roulin D, Labgaa I, et al. Novelties on the management of alveolar echinococcosis[J]. Rev Med Suisse, 2023, 19(831): 1192-1195.
[4]	Chai JY, Jung BK, Hong SJ. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: an update[J]. Korean J Parasitol, 2021, 59(3): 189-225.
[5]	Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3): 151-166.
[6]	Gao CC, Bai J, Han H, et al. The versatility of macrophage heterogeneity in liver fibrosis[J]. Front Immunol, 2022, 13: 968879.
[7]	Guillot A, Tacke F. Liver macrophages: old dogmas and new insights[J]. Hepatol Commun, 2019, 3(6): 730-743.
[8]	Wang MM, An XQ, Zhou HQ, et al. Research progress in hepaticalveolar echinococcosis leading to cirrhosis[J]. Chin J Zoo-noses, 2023, 39(11): 1130-1135. (in Chinese)
	(王苗苗, 安秀青, 周鸿乾, 等. 肝多房棘球蚴病导致肝硬化的研究进展[J]. 中国人兽共患病学报, 2023, 39(11): 1130-1135.)
[9]	Min HY, Tian FM, Zhang JY, et al. Role of monocyte chemotactic protein 1-mediated monocyte infiltration in liver fibrosis of alveolar echinococcosis[J]. J Pathog Biol, 2023, 18(4): 400-405, 410. (in Chinese)
	(闵宏悦, 田凤鸣, 张靖仪, 等. MCP-1介导单核细胞浸润在泡型包虫病肝纤维化中的作用[J]. 中国病原生物学杂志, 2023, 18(4): 400-405, 410.)
[10]	Ma YY, Li JJ, Liu YM, et al. Identification and exploration of a new M2 macrophage marker MTLN in alveolar echinococcosis[J]. Int Immunopharmacol, 2024, 131: 111808.
[11]	Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis[J]. J Hepatol, 2014, 60(5): 1090-1096.
[12]	Zhang RJ, Pang HS, Li JZ, et al. Mechanism of hepatic fibrosis associated with Echinococcus: a review[J]. Chin J Schistosomiasis Contr, 2022, 34(6): 646-653. (in Chinese)
	(张仁杰, 庞华胜, 李景中, 等. 棘球绦虫诱导肝纤维化机制研究进展[J]. 中国血吸虫病防治杂志, 2022, 34(6): 646-653.)
[13]	Zhang LH, Chen G, Chong SG, et al. Research progress on the immune regulation mechanism in alveolar echinococcosis[J]. Chin J Parasitol Parasit Dis, 2022, 40(1): 109-113, 120. (in Chinese)
	(张伶慧, 陈根, 种世桂, 等. 多房棘球蚴病中免疫细胞调控机制的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(1): 109-113, 120.)
[14]	Jia R, Hui Y, Yan SG, et al. Research progress on relationship between macrophage M1/M2 polarization and immune in-flammatory diseases[J]. Chin J Immunol, 2021, 37(22): 2791-2797. (in Chinese)
	(贾瑞, 惠毅, 闫曙光, 等. 巨噬细胞M1/M2型极化与免疫炎症性疾病关系的研究进展[J]. 中国免疫学杂志, 2021, 37(22): 2791-2797.)
[15]	Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018, 233(9): 6425-6440.
[16]	Novo E, Marra F, Zamara E, et al. Overexpression of bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans[J]. Gut, 2006, 55(8): 1174-1182.
[17]	Emery I, Liance M, Deriaud E, et al. Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice[J]. Parasite Immunol, 1996, 18(9): 463-472.
[18]	Fujiu K, Manabe I, Nagai R. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice[J]. J Clin Invest, 2011, 121(9): 3425-3441.
[19]	Feng N, Zhang CT, Cao WY, et al. CD19⁺CD24^hiCD38^hi regulatory B cells involved in hepatic alveolar hydatid infection in humans[J]. Ann Clin Lab Sci, 2019, 49(3): 338-343.
[20]	Wang J, Gottstein B. Immunoregulation in larval Echinococcus multilocularis infection[J]. Parasite Immunol, 2016, 38(3): 182-192.
[21]	Muraille E, Leo O, Moser M. Th1/Th2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism?[J]. Front Immunol, 2014, 5: 603.
[22]	Wynn TA, Chawla A, Pollard JW. Macro-phage biology in development, homeostasis and disease[J]. Nature, 2013, 496(7446): 445-455.
[23]	Braga TT, Agudelo JSH, Camara NOS. Macrophages during the fibrotic process: M2 as friend and foe[J]. Front Immunol, 2015, 6: 602.
[24]	Wang H, Zhang CS, Fang BB, et al. Dual role of hepatic macrophages in the establishment of the Echinococcus multilocularis metacestode in mice[J]. Front Immunol, 2020, 11: 600635.
[25]	Yang HD, Cheng H, Dai RR, et al. Macrophage polarization in tissue fibrosis[J]. PeerJ, 2023, 11: e16092.
[26]	Chong SG, Chen G, Dang ZS, et al. Echinococcus multilocularis drives the polarization of macrophages by regulating the RhoA-MAPK signaling pathway and thus affects liver fibrosis[J]. Bioengineered, 2022, 13(4): 8747-8758.
[27]	Atri C, Guerfali FZ, Laouini D. Role of human macrophage polarization in inflammation during infectious diseases[J]. Int J Mol Sci, 2018, 19(6): 1801.
[28]	Xu FY, Liu CW, Zhou DD, et al. TGF-β/SMAD pathway and its regulation in hepatic fibrosis[J]. J Histochem Cytochem, 2016, 64(3): 157-167.
[29]	Luo Y, Shao LJ, Chang JH, et al. M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion[J]. Blood Adv, 2018, 2(8): 859-870.
[30]	Gandhi CR. Hepatic stellate cell activation and pro-fibrogenic signals[J]. J Hepatol, 2017, 67(5): 1104-1105.
[31]	Wang Z, Du KL, Jin NK, et al. Macrophage in liver fibrosis: identities and me-chanisms[J]. Int Immunopharmacol, 2023, 120: 110357.
[32]	Liu YM, Tian FM, Shan JY, et al. Kupffer cells: Important participant of hepatic alveolar echinococcosis[J]. Front Cell Infect Microbiol, 2020, 10: 8.
[33]	Fabriek BO, van Bruggen R, Deng DM, et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria[J]. Blood, 2009, 113(4): 887-892.
[34]	Wallace K, Burt AD, Wright MC. Liver fibrosis[J]. Biochem J, 2008, 411(1): 1-18.
[35]	Wang JH, Zhang CS, Wei XF, et al. TGF-β and TGF-β/Smad signaling in the interactions between Echinococcus multilocularis and its hosts[J]. PLoS One, 2013, 8(2): e55379.
[36]	Dewidar B, Meyer C, Dooley S, et al. TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019[J]. Cells, 2019, 8(11): 1419.
[37]	Huang Y, Huang C, Li J. Effect of cyto-kines secreted from Kupffer cell on HSC proliferation, apoptosis in hepatic fibrosis process[J]. Chin Pharmacol Bull, 2010, 26(1): 9-13. (in Chinese)
	(黄艳, 黄成, 李俊. 肝纤维化病程中Kupffer细胞分泌的细胞因子对肝星状细胞活化增殖、凋亡的调控[J]. 中国药理学通报, 2010, 26(1): 9-13.)
[38]	Su SB, Qin SY, Xian XL, et al. Interleu-kin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis[J]. Life Sci, 2021, 264: 118677.
[39]	Davies LC, Jenkins SJ, Allen JE, et al. Tissue-resident macrophages[J]. Nat Immunol, 2013, 14(10): 986-995.
[40]	van der Heide D, Weiskirchen R, Bansal R. Therapeutic targeting of hepatic macro-phages for the treatment of liver diseases[J]. Front Immunol, 2019, 10: 2852.
[41]	Karlmark KR, Weiskirchen R, Zimmer-mann HW, et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis[J]. He-patology, 2009, 50(1): 261-274.
[42]	Ju C, Tacke F. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies[J]. Cell Mol Immunol, 2016, 13(3): 316-327.
[43]	Liaskou E, Zimmermann HW, Li KK, et al. Monocyte subsets in human liver disease show distinct phenotypic and functional cha-racteristics[J]. Hepatology, 2013, 57(1): 385-398.
[44]	Yona S, Kim KW, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis[J]. Immunity, 2013, 38(1): 79-91.
[45]	Wen YK, Lambrecht J, Ju C, et al. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities[J]. Cell Mol Immunol, 2021, 18(1): 45-56.
[46]	Ramachandran P, Pellicoro A, Vernon MA, et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis[J]. Proc Natl Acad Sci USA, 2012, 109(46): E3186-E3195.
[47]	Cheng D, Chai J, Wang HW, et al. Hepatic macrophages: key players in the development and progression of liver fibrosis[J]. Liver Int, 2021, 41(10): 2279-2294.
[48]	Bresson-Hadni S, Petitjean O, Mon-not-Jacquard B, et al. Cellular localisations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha mRNA in a parasitic granulomatous disease of the liver, alveolar echinococcosis[J]. Eur Cytokine Netw, 1994, 5(5): 461-468.
[49]	Tian FM, Jiang T, Qi XW, et al. Role of cytokines on the progression of liver fibrosis in mice infected with Echinococcus multilocularis[J]. Infect Drug Resist, 2021, 14: 5651-5660.
[50]	Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis[J]. Immunity, 2016, 44(3): 450-462.
[51]	Pradere JP, Kluwe J, De Minicis S, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice[J]. Hepatology, 2013, 58(4): 1461-1473.
[52]	Negash AA, Ramos HJ, Crochet N, et al. IL-1β production through the NLRP3 inflam-masome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease[J]. PLoS Pathog, 2013, 9(4): e1003330.

巨噬细胞调控多房棘球蚴病所致肝纤维化研究进展

Research progress of macrophage regulation of liver fibrosis induced by alveolar echinococcosis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 52

相关文章 15

编辑推荐

Metrics

本文评价

[1]	黎广, 姜慧娇, 杜云峰, 舒敏, 罗雨盟, 朱令懿, 陈雪玲, 吴向未. 体外小鼠巨噬细胞与细粒棘球蚴原头节的相互作用[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 52-60.
[2]	邓冰清, 阿迪莱·多力坤, 李寅时, 阿比旦·艾尼瓦尔, 孙胜, 肖雯颖, 葛聪蕙, 唐娜, 姜涛, 王慧, 张传山, 李静. 多房棘球蚴感染小鼠腹膜腔免疫细胞迁移及其功能变化[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 76-83.
[3]	魏盼龙, 张耀刚, 张涛, 杨紫晗, 侯静, 田美媛, 黄登亮, 马艳艳. 多房棘球蚴感染巨噬细胞中CD47和SIRPα表达变化与抑制作用的研究[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 84-90.
[4]	李振伟, 王成, 王志鑫, 刘津铭, 赵乾, 王海久, 谢智. 基于三维可视化技术指导肝多房棘球蚴病手术方案的应用研究[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(6): 737-743.
[5]	祖力皮喀尔·图孙尼亚孜, 蒋铁民, 温浩. 肝多房棘球蚴病的手术治疗进展[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(6): 783-789.
[6]	赵涵玥, 李锦田, 薛俊隆, 卡力比夏提·艾木拉江, 林仁勇, 吐尔干艾力·阿吉. 多房棘球蚴感染晚期小鼠肝脏中NK1.1的表达对T细胞功能的影响[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(5): 594-600.
[7]	徐刚, 毛艺, 李江, 张宏伟, 张永国, 吴向未, 彭心宇, 孙红, 杨婧, 陈骞, 张示杰. 多房棘球蚴通过肝脏p38MAPK通路调控棘球蚴自身生长[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(4): 447-453.
[8]	蒉嫣, 薛垂召, 王旭, 刘白雪, 王莹, 王立英, 杨诗杰, 韩帅, 许学年. 2022年全国棘球蚴病防治工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(1): 8-16.
[9]	逯君霞, 许军英, 赵彬, 王芊文, 李文华, 耿玉庆, 侯隽, 吴向未, 陈雪玲. 细粒棘球蚴感染诱导巨噬细胞表达CD73和A2AR抑制炎症反应[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(5): 559-566.
[10]	朱爱娅, 王旭, 王江友, 王颖, 李杨, 宋珊, 耿燕, 兰子尧, 戴佳芮. 贵州省儿童多房棘球蚴病1例[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(4): 520-523.
[11]	娆琬·托勒洪, 阿不都撒拉木·阿不力克木, 杨凌菲, 陈璐, 李钊, 贾芳, 宋涛. 超声表现诊断肝多房棘球蚴病的效果评价及因素分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(3): 312-318.
[12]	蒉嫣, 薛垂召, 王旭, 刘白雪, 王莹, 王立英, 杨诗杰, 韩帅, 伍卫平, 肖宁. 2021年全国棘球蚴病防治进展[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 142-148.
[13]	马慧, 种世桂, 陈根, 张伶慧, 秦俊梅, 赵玉敏. 多房棘球蚴病相关细胞信号通路的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 223-227.
[14]	焦红杰, 齐文静, 郭刚, 包建玲, 吴川川, 宋传龙, 李军, 张文宝, 严媚. 细粒棘球蚴抗原B对小鼠巨噬细胞RAW264.7的极化作用[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(1): 23-28.
[15]	安秀青, 王苗苗, 周鸿乾, 孟凯, 蔡剑平, 刘光辉, 阿吉德, 杨金煜. 肝多房棘球蚴病微血管密度的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(6): 792-797.